Form 8-K - Current report:
SEC Accession No. 0000950170-24-122792
Filing Date
2024-11-07
Accepted
2024-11-07 07:15:11
Documents
13
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rapp-20241107.htm   iXBRL 8-K 38947
2 EX-99.1 rapp-ex99_1.htm EX-99.1 191822
3 GRAPHIC img173444502_0.jpg GRAPHIC 4104
  Complete submission text file 0000950170-24-122792.txt   375082

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rapp-20241107.xsd EX-101.SCH 26973
15 EXTRACTED XBRL INSTANCE DOCUMENT rapp-20241107_htm.xml XML 5118
Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42121 | Film No.: 241433146
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)